240 related articles for article (PubMed ID: 11501196)
1. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
Brinkman K
J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
[No Abstract] [Full Text] [Related]
2. Clinical manifestations of mitochondrial toxicity.
Walker UA
J HIV Ther; 2001 Mar; 6(1):17-21. PubMed ID: 11501197
[No Abstract] [Full Text] [Related]
3. Mitochondrial toxicity.
Scoular A
J HIV Ther; 2001 Mar; 6(1):1-3. PubMed ID: 11501195
[No Abstract] [Full Text] [Related]
4. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
Shah SS; Rodriguez T; McGowan JP
Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
[TBL] [Abstract][Full Text] [Related]
5. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
McComsey G
AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
[TBL] [Abstract][Full Text] [Related]
6. Lactic acidosis and antiretroviral therapy: a case report and literature review.
Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
[TBL] [Abstract][Full Text] [Related]
7. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
[TBL] [Abstract][Full Text] [Related]
8. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
[TBL] [Abstract][Full Text] [Related]
9. Use of Tris-hydroxymethyl aminomethane in severe lactic acidosis due to highly active antiretroviral therapy: a case report.
Marfo K; Garala M; Kvetan V; Gasperino J
J Clin Pharm Ther; 2009 Feb; 34(1):119-23. PubMed ID: 19125910
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
Viganò A; Giacomet V
Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
[No Abstract] [Full Text] [Related]
11. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
[No Abstract] [Full Text] [Related]
13. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
Khouri S; Cushing H
AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial toxicity and lactic acidosis.
Proj Inf Perspect; 2000 Mar; (29):10-1. PubMed ID: 12772662
[TBL] [Abstract][Full Text] [Related]
15. Of power plants and energy shortages.
TreatmentUpdate; 2001 May; 13(1):3-4. PubMed ID: 11570256
[No Abstract] [Full Text] [Related]
16. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
Hernández Pérez E; Dawood H
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):109-12. PubMed ID: 20484736
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
Fielder J; Rambiki K
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside analogues and mitochondrial toxicity.
Fleischer R; Boxwell D; Sherman KE
Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
[TBL] [Abstract][Full Text] [Related]
19. Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitors.
Boffito M; Marietti G; Audagnotto S; Raiter R; Di Perri G
Clin Infect Dis; 2002 Feb; 34(4):558-9. PubMed ID: 11797190
[No Abstract] [Full Text] [Related]
20. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
Dieterich DT
AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
